TrialJAMA network open2021

Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical Trial.

Antonio Finelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.